ECSP10010357A - Nuevos derivados croménicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen - Google Patents
Nuevos derivados croménicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienenInfo
- Publication number
- ECSP10010357A ECSP10010357A EC2010010357A ECSP10010357A ECSP10010357A EC SP10010357 A ECSP10010357 A EC SP10010357A EC 2010010357 A EC2010010357 A EC 2010010357A EC SP10010357 A ECSP10010357 A EC SP10010357A EC SP10010357 A ECSP10010357 A EC SP10010357A
- Authority
- EC
- Ecuador
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- preparation procedure
- new chrome
- derivatives
- Prior art date
Links
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical class [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- -1 3,4-dioxocyclobutenyl Chemical group 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a los compuestos de fórmula (I)en la que R1 y R2 forman juntos la cadena carbonada siguiente :en la que :¢ R3 representa un átomo de hidrógeno o un grupo alquilo,¢ R4 representa un átomo de hidrógeno, un grupo alquilo, arilo, heteroarilo,3,4-dioxociclobutenilo, alquilcarbonilo, cicloalquilcarbonilo, heterocicloalquilcarbonilo, benzoilo, arilsulfonilo o heteroarilsulfonilo, estando cada uno de estos grupos sustituido opcionalmente,¢ o R3 y R4 forman junto con el átomo de nitrógeno al que están unidos un ciclo que contiene de 5 a 8 eslabones, pudiendo estar el ciclo así formado sustituido opcionalmente.Medicamentos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0903572A FR2948372B1 (fr) | 2009-07-21 | 2009-07-21 | Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010357A true ECSP10010357A (es) | 2011-02-28 |
Family
ID=41856518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010357A ECSP10010357A (es) | 2009-07-21 | 2010-07-20 | Nuevos derivados croménicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8247441B2 (es) |
| EP (1) | EP2277882A1 (es) |
| JP (1) | JP2011026319A (es) |
| KR (1) | KR20110009064A (es) |
| CN (1) | CN101962384B (es) |
| AR (1) | AR077492A1 (es) |
| AU (1) | AU2010202876A1 (es) |
| BR (1) | BRPI1002409A2 (es) |
| CA (1) | CA2709341A1 (es) |
| CL (1) | CL2010000743A1 (es) |
| CO (1) | CO6280049A1 (es) |
| CR (1) | CR11566A (es) |
| CU (1) | CU20100149A7 (es) |
| EA (1) | EA017774B1 (es) |
| EC (1) | ECSP10010357A (es) |
| FR (1) | FR2948372B1 (es) |
| GE (1) | GEP20125545B (es) |
| IL (1) | IL206885A0 (es) |
| MA (1) | MA32342B1 (es) |
| MX (1) | MX2010007799A (es) |
| NZ (1) | NZ586855A (es) |
| PE (1) | PE20110156A1 (es) |
| SG (1) | SG168482A1 (es) |
| TW (1) | TW201109337A (es) |
| UY (1) | UY32768A (es) |
| WO (1) | WO2011010014A1 (es) |
| ZA (1) | ZA201005203B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3495363B1 (en) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect |
| US11447484B2 (en) | 2018-01-26 | 2022-09-20 | Shionogi & Co., Ltd. | Cyclic compound having dopamine D3 receptor antagonistic effect |
| TW201938537A (zh) | 2018-01-26 | 2019-10-01 | 日商鹽野義製藥股份有限公司 | 具有多巴胺ｄ３受體拮抗作用的稠環化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2722194B1 (fr) * | 1994-07-06 | 1996-08-23 | Adir | Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent |
| AU5272296A (en) * | 1995-04-06 | 1996-10-23 | Novo Nordisk A/S | Benzopyranopyrrole compounds, their preparation and use |
| FR2764890B1 (fr) * | 1997-06-24 | 1999-08-27 | Adir | Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
-
2009
- 2009-07-21 FR FR0903572A patent/FR2948372B1/fr not_active Expired - Fee Related
-
2010
- 2010-07-06 PE PE2010000440A patent/PE20110156A1/es not_active Application Discontinuation
- 2010-07-07 UY UY0001032768A patent/UY32768A/es unknown
- 2010-07-07 AU AU2010202876A patent/AU2010202876A1/en not_active Abandoned
- 2010-07-08 IL IL206885A patent/IL206885A0/en unknown
- 2010-07-08 SG SG201004962-5A patent/SG168482A1/en unknown
- 2010-07-12 CL CL2010000743A patent/CL2010000743A1/es unknown
- 2010-07-13 CR CR11566A patent/CR11566A/es not_active Application Discontinuation
- 2010-07-16 CU CU20100149A patent/CU20100149A7/es unknown
- 2010-07-16 MX MX2010007799A patent/MX2010007799A/es unknown
- 2010-07-16 NZ NZ586855A patent/NZ586855A/en not_active IP Right Cessation
- 2010-07-16 CA CA2709341A patent/CA2709341A1/fr not_active Abandoned
- 2010-07-16 CO CO10087224A patent/CO6280049A1/es active IP Right Grant
- 2010-07-16 GE GEAP201011892A patent/GEP20125545B/en unknown
- 2010-07-19 MA MA33038A patent/MA32342B1/fr unknown
- 2010-07-20 EP EP10290411A patent/EP2277882A1/fr not_active Withdrawn
- 2010-07-20 WO PCT/FR2010/000519 patent/WO2011010014A1/fr active Application Filing
- 2010-07-20 US US12/804,355 patent/US8247441B2/en not_active Expired - Fee Related
- 2010-07-20 AR ARP100102637A patent/AR077492A1/es unknown
- 2010-07-20 JP JP2010162384A patent/JP2011026319A/ja not_active Ceased
- 2010-07-20 BR BRPI1002409-3A patent/BRPI1002409A2/pt not_active Application Discontinuation
- 2010-07-20 EC EC2010010357A patent/ECSP10010357A/es unknown
- 2010-07-20 TW TW099123875A patent/TW201109337A/zh unknown
- 2010-07-20 EA EA201001041A patent/EA017774B1/ru not_active IP Right Cessation
- 2010-07-21 ZA ZA2010/05203A patent/ZA201005203B/en unknown
- 2010-07-21 KR KR1020100070584A patent/KR20110009064A/ko not_active Application Discontinuation
- 2010-07-21 CN CN2010102347598A patent/CN101962384B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2948372B1 (fr) | 2011-07-22 |
| CL2010000743A1 (es) | 2011-07-08 |
| FR2948372A1 (fr) | 2011-01-28 |
| GEP20125545B (en) | 2012-05-25 |
| CR11566A (es) | 2010-09-13 |
| CO6280049A1 (es) | 2011-05-20 |
| EA017774B1 (ru) | 2013-03-29 |
| MX2010007799A (es) | 2011-02-03 |
| UY32768A (es) | 2011-01-31 |
| CU20100149A7 (es) | 2012-03-15 |
| CA2709341A1 (fr) | 2011-01-21 |
| ZA201005203B (en) | 2011-03-30 |
| US8247441B2 (en) | 2012-08-21 |
| NZ586855A (en) | 2011-11-25 |
| CN101962384B (zh) | 2013-04-10 |
| US20110021490A1 (en) | 2011-01-27 |
| BRPI1002409A2 (pt) | 2012-05-15 |
| MA32342B1 (fr) | 2011-06-01 |
| KR20110009064A (ko) | 2011-01-27 |
| CN101962384A (zh) | 2011-02-02 |
| PE20110156A1 (es) | 2011-03-19 |
| AR077492A1 (es) | 2011-08-31 |
| JP2011026319A (ja) | 2011-02-10 |
| TW201109337A (en) | 2011-03-16 |
| AU2010202876A1 (en) | 2011-02-10 |
| IL206885A0 (en) | 2010-12-30 |
| EP2277882A1 (fr) | 2011-01-26 |
| SG168482A1 (en) | 2011-02-28 |
| WO2011010014A1 (fr) | 2011-01-27 |
| EA201001041A1 (ru) | 2011-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123308T1 (el) | Αναστολεας ινωσης | |
| ECSP099216A (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| NI200900037A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-alfa] piridinas, su preparación y su aplicación en terapéutica. | |
| NI201000134A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| CY1117157T1 (el) | Υποκατεστημενο παραγωγο ισοκινολινης | |
| CO6290657A2 (es) | Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-alfa]piridinas su preparacion y su aplicacion en terapeutica | |
| UY30105A1 (es) | Derivados nuevos azufrados de urea cíclica, su preparación y su utilización farmacéutica como inhibidores de quinasas. | |
| CO6150147A2 (es) | Derivados de 5,6-bisaril-2-piridin-carboxamida su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii | |
| NI200900147A (es) | Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
| GT200700084A (es) | Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmaceuticas que los contienen. | |
| CO6160310A2 (es) | Nuevos derivados imidazolonas su preparacion como medicamentos composiciones farmaceuticas utilizacion como inhibidores de proteinas quinasas principalmente cdc7 | |
| ECSP10010357A (es) | Nuevos derivados croménicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| ECSP12011671A (es) | Octasacáridos n-acilos activadores de los receptores de los fgf, su preparación y su aplicación en terapéutica | |
| CU20130037A7 (es) | Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CU20120041A7 (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| UY32702A (es) | Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
| CO6331311A2 (es) | Derivados de n-heterociclico-6-heterociclico-imidazo[1,2-alfa]piriidina-2-carboxamidas su preparacion y su aplicacion en terapeutica | |
| UY30879A1 (es) | Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen. | |
| CR11599A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CU20090134A7 (es) | Nuevos derivados tricíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CU20070216A7 (es) | Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen | |
| CO6280059A1 (es) | Nuevos derivados de azabiciclos (3.2.0) hept-3-ilo su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |